{"article": [{"url": "https://www.marketwatch.com/story/trump-white-house-accedes-to-fdas-new-vaccine-safety-guidelines-11602016191", "published": 1602002240.0, "headline": "Trump White House accedes to FDA's new vaccine safety guidelines", "body": "FDA Commissioner Stephen Hahn speaks at the briefing-room podium in August as President Donald Trump looks on. Saul Loeb/Agence France-Presse/Getty Images The White House endorsed the U.S. Food and Drug Administration's plans for assessing whether a COVID-19 vaccine should be given widely, casting aside objections to requirements that would likely mean a shot won't be cleared until after Election Day, people familiar with the matter said. The FDA promptly issued the guidelines on Tuesday afternoon, saying it hopes the release \"helps the public understand our science-based decision-making process that assures vaccine quality, safety and efficacy for any vaccine that is authorized or approved.\" See: Here are the FDA's COVID-19 vaccine guidelines that the White House opposed Don't miss: Trump on FDA's plan to pause vaccine clearance long enough to track trial participants: 'That sounds like a political move' The White House didn't immediately respond to a request for comment. An expanded version of this report appears at WSJ.com. Trending at WSJ.com: Will Biden or Trump be the winner on Nov. 3? Here's what the stock market thinks Back at the White House, it's off with the face mask for Donald Trump"}]}